CIBC Asset Management’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,280
Closed -$192K 1528
2022
Q1
$192K Hold
10,280
﹤0.01% 1406
2021
Q4
$220K Buy
+10,280
New +$203K ﹤0.01% 1327

Other funds holding OCDX

CIBC Asset Management's OCDX Position: Q2 2022 in Review

CIBC Asset Management sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 10,280 shares — an estimated $192K sold.

CIBC Asset Management first reported a position in OCDX in Q4 2021 and held it in 2 quarters. The position peaked at $220K in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • CIBC Asset Management reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • CIBC Asset Management sold 10,280 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $192K.
  • CIBC Asset Management first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q4 2021 and held it in 2 quarters.
  • CIBC Asset Management's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $220K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on CIBC Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.